Squire Patton Boggs has advised the shareholders of Oxford PharmaGenesis, the HealthScience communications consultancy, on the acquisition of the business by Klick Health.
The Squire Patton Boggs team was led by Corporate partner Mark Yeo and senior associate Simon Ayling, and included Summer Prior, Matthew Vautrey, Katie Alexander and Sunny Razza in Corporate, Patrick Ford and Alice Jenkinson in Tax Strategy & Benefits, Jo Johnson in Labour & Employment, and Alex Weatherall in Real Estate.
Oxford PharmaGenesis is the largest independent company in the healthcare communications sector. Founded in 1998, the award-winning organization comprises a team of 500 working from North America, Europe, and Asia-Pacific. The only company in its sector to be named a three-time winner of the King’s (formerly Queen’s) Award for Enterprise, the UK’s most prestigious business accolade, Oxford PharmaGenesis received the 2026 Longitude Prize on ALS and has been named Communique Awards’ Medical Affairs Agency of the Year.
Klick Health is the world’s largest independent commercialization partner for life sciences, providing marketing and advertising, media strategy and purchasing, medical affairs and medical communications, value and market access services, as well as technology and analytics consulting among its specialized offerings. Established in 1997, Klick Health (including Klick Katalyst and btwelve) has offices in New York, Philadelphia, Saratoga Springs, Toronto, London, São Paulo, and Singapore.
